Retractable Technologies, Inc. (RVP) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Retractable Technologies, Inc. (RVP) trades at $0.70 with AI Score 37/100 (Grade D). Retractable Technologies, Inc. specializes in designing, developing, and manufacturing safety syringes and medical products. Market cap: $21.0M, Sector: Healthcare.
Price as of Jul 20, 2026 · Last analyzed: May 10, 2026Analyst Coverage for RVP: RVP does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates RVP against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
RVP: 2/3 scored disciplines lean bearish. Dominant signal: Ray Dalio bullish.
How is this calculated? →Why this analysis is different
- A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
- An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
- Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.
Retractable Technologies, Inc. (RVP) Healthcare & Pipeline Overview
Retractable Technologies, Inc. (RVP) focuses on innovative safety syringes and medical devices, addressing the critical need for sharps injury prevention in healthcare. With a global presence, RVP competes in the medical instruments and supplies market, emphasizing safety features and distribution through diverse channels.
What Is the Investment Thesis for RVP?
Retractable Technologies, Inc. presents a focused investment opportunity within the medical safety device market. The company's emphasis on safety syringes and related products aligns with the ongoing need to reduce needlestick injuries and improve healthcare safety. While the company's market capitalization is approximately $0.02 billion, potential investors should carefully consider the company's negative profit margin of -32.8% and a low gross margin of 0.1%. Growth catalysts include expanding distribution networks and increasing adoption of safety-engineered medical devices. Key risks include competition from larger medical device manufacturers and the ability to achieve profitability. Investors should evaluate Retractable Technologies' ability to scale production, manage costs, and capitalize on regulatory tailwinds favoring safety devices.
Based on FMP financials and quantitative analysis
RVP Key Highlights
- Retractable Technologies, Inc. operates in the medical instruments and supplies industry, focusing on safety syringes and related products.
- The company's market capitalization is approximately $0.02 billion.
- Retractable Technologies has a negative profit margin of -32.8%.
- The company's gross margin is 0.1%.
- Retractable Technologies distributes its products through general line and specialty distributors, as well as through international distributors and a direct marketing network.
Who Are RVP's Competitors?
RVP is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| BDX Becton, Dickinson and Company | $154.48 | -2.33% | $56.0B | 73 |
| NVO Novo Nordisk A/S | $49.61 | -1.41% | $220B | 51 |
| ZTEK Zentek Ltd. | $0.46 | -2.13% | $49.5M | 63 |
| OMIC Singular Genomics Systems, Inc. | $20.01 | +0.00% | $50.8M | 61 |
| DXR Daxor Corporation | $10.91 | +0.05% | $55.0M | 58 |
| NYXH Nyxoah S.A. | $1.56 | -0.64% | $61.8M | 69 |
| BLMHF Bloom Health Partners Inc. | $0.11 | +0.00% | $5.22M | 51 |
| NSTG NanoString Technologies, Inc. | $0.11 | -37.43% | $5.07M | 51 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are RVP's Key Strengths?
- Proprietary VanishPoint technology
- Focus on safety-engineered medical devices
- Established distribution network
- Commitment to reducing needlestick injuries
What Are RVP's Weaknesses?
- Limited product diversification
- Negative profit margin
- Small market capitalization
- Dependence on specific product lines
What Could Drive RVP Stock Higher?
- Expansion into new international markets, targeting regions with high healthcare safety standards.
- Increasing regulatory mandates for safety-engineered medical devices in North America and Europe.
- Growing awareness of needlestick injuries and healthcare-associated infections driving demand for safety syringes.
- Potential partnerships with larger medical device companies to expand product distribution.
What Are the Key Risks for RVP?
- Financial-distress signal — its Altman Z-Score of 0.83 sits in the distress zone (elevated bankruptcy risk).
- Negative return on equity (-8.5%) — the business is not currently generating profit on shareholder capital.
- Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
- Competition from larger medical device manufacturers with greater resources and broader product portfolios.
- Fluctuations in raw material costs impacting production expenses and profitability.
- Regulatory changes affecting product approvals and market access.
- Dependence on key distributors and potential disruptions in the supply chain.
- Patent expirations on key technologies leading to increased competition from generic alternatives.
What Are the Growth Opportunities for RVP?
- Expanding Distribution Networks: Retractable Technologies can grow by expanding its distribution networks both domestically and internationally. Focusing on partnerships with larger distributors and penetrating underserved markets in South America and Asia could significantly increase sales volume. The global market for medical devices is projected to reach $600 billion by 2028, providing a substantial opportunity for increased market share through strategic distribution agreements. Timeline: Ongoing.
- Increasing Adoption of Safety-Engineered Devices: With growing awareness of healthcare worker safety and stringent regulations mandating the use of safety-engineered devices, Retractable Technologies can capitalize on increasing adoption rates. Focusing on educating healthcare facilities about the benefits of retractable syringes and participating in industry conferences can drive demand. The market for safety syringes is expected to grow at a CAGR of 6% over the next five years. Timeline: Ongoing.
- Product Innovation and Diversification: Retractable Technologies can invest in research and development to expand its product portfolio beyond syringes. Developing new safety devices for other medical procedures, such as blood collection and IV administration, can broaden the company's addressable market. The market for advanced medical technologies is projected to grow at a CAGR of 8% through 2027. Timeline: 2027-2029.
- Strategic Acquisitions and Partnerships: Retractable Technologies can pursue strategic acquisitions or partnerships to enhance its product offerings and market reach. Acquiring smaller companies with complementary technologies or partnering with larger medical device manufacturers can accelerate growth. The healthcare industry is witnessing increased consolidation, presenting opportunities for synergistic collaborations. Timeline: 2027-2028.
- Government Contracts and Public Health Initiatives: Retractable Technologies can actively pursue government contracts and participate in public health initiatives aimed at improving healthcare safety. Collaborating with government agencies and non-profit organizations can provide access to large-scale procurement opportunities and enhance the company's reputation. Government spending on healthcare is expected to increase in the coming years, creating opportunities for companies offering innovative safety solutions. Timeline: Ongoing.
What Opportunities Does RVP Have?
- Expanding into new geographic markets
- Increasing adoption of safety devices
- Developing new safety-engineered products
- Partnering with larger medical device companies
What Threats Does RVP Face?
- Competition from larger medical device manufacturers
- Regulatory changes impacting product approvals
- Price pressures from healthcare providers
- Patent expirations
What Are RVP's Competitive Advantages?
- Proprietary retractable needle technology
- Focus on safety features
- Established distribution network
- Brand recognition in safety syringe market
What Does RVP Do?
Retractable Technologies, Inc., founded in 1994 and headquartered in Little Elm, Texas, is dedicated to the design, development, manufacture, and marketing of safety syringes and other safety medical products. The company's primary focus is on enhancing safety within the healthcare profession by reducing the risk of needlestick injuries and improving patient outcomes. Its product portfolio includes VanishPoint insulin syringes, tuberculin syringes, insulin syringes, allergy antigen syringes, small diameter tube adapters, blood collection tube holders, allergy trays, IV safety catheters, Patient Safe syringes and Luer Caps, VanishPoint blood collection sets, EasyPoint needles, and VanishPoint autodisable syringes. These products are designed with retractable needle technology to minimize accidental punctures and cross-contamination. Retractable Technologies distributes its products through a network of general line and specialty distributors, as well as through international distributors and a direct marketing network, serving healthcare providers across the United States, North and South America, and internationally. The company continues to innovate in the safety medical device sector, striving to meet the evolving needs of healthcare professionals and patients alike.
What Products and Services Does RVP Offer?
- Designs and develops safety syringes.
- Manufactures safety medical products.
- Markets safety syringes and medical products to healthcare professionals.
- Offers VanishPoint insulin syringes.
- Provides IV safety catheters.
- Sells VanishPoint blood collection sets.
- Distributes EasyPoint needles.
- Offers VanishPoint autodisable syringes.
How Does RVP Make Money?
- Designs and manufactures safety syringes and medical products.
- Sells products through distributors and direct marketing.
- Focuses on reducing needlestick injuries in healthcare settings.
What Industry Does RVP Operate In?
Retractable Technologies operates within the medical instruments and supplies industry, a sector driven by technological advancements, regulatory requirements, and the increasing demand for safer medical practices. The market for safety syringes and medical devices is influenced by stringent healthcare regulations aimed at reducing healthcare-associated infections and needlestick injuries. Competitors range from large, diversified medical device manufacturers to smaller, specialized firms. Retractable Technologies carves a niche by focusing on retractable needle technology, aiming to provide cost-effective solutions for healthcare providers. The industry is characterized by ongoing innovation, with companies continually developing advanced safety features and user-friendly designs.
Who Are RVP's Key Customers?
- Hospitals and clinics
- Healthcare professionals
- Distributors of medical supplies
- Government healthcare agencies
- International healthcare organizations
RVP Valuation & Market Position
With a $21.0M market cap, Retractable Technologies, Inc. sits in the micro-cap segment of the market. Relative to its peer group, RVP's quantitative score of 37/100 is below the peer average of 61/100.
Net buyingInsider Activity
The most recent 12 insider filings for Retractable Technologies, Inc. break down as 0 sales and 12 purchases. On net that is roughly 175K shares acquired (about $157K) — insiders putting money in tends to read as conviction.
F-Score 3/9Financial Health
Retractable Technologies, Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of 0.83 places it in the distress zone, a signal of elevated financial risk.
ROE -8%Key Financial Metrics
Return on equity for Retractable Technologies, Inc. stands at -8.5%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -4.6%, showing how much profit it generates from its asset base. Its free cash flow yield is -34.4%, a gauge of the cash the business throws off relative to its market value. A current ratio of 5.74 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -29.2%, the inverse of the P/E and a quick read on earnings relative to price.
RVP Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- RVP's recent insider buying suggests those in the know see long-term value, a potential bullish signal.
- The community buzz seems to be picking up, with more positive mentions lately, hinting at growing confidence.
- Market perception appears to be shifting, with RVP gaining attention as a potential player in its sector.
- There's a sense that RVP might be undervalued, sparking interest from investors looking for overlooked opportunities.
Bear Case
- Despite positive sentiment, some worry about RVP's ability to scale production to meet potential demand.
- A segment of the community is skeptical, citing past performance issues and unfulfilled promises.
- Market perception is still mixed, with some viewing RVP as a high-risk, high-reward play, causing hesitation.
- Concerns linger about increased competition eroding RVP's market share, a potential drag on future growth.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · February 2026
RVP Latest News
-
Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders
businesswire.com · Jun 30, 2026
-
12 Health Care Stocks Moving In Friday's After-Market Session
benzinga · Jun 12, 2026
-
Stocks That Hit 52-Week Lows On Friday
benzinga · Sep 16, 2022
RVP Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for RVP.
Price Targets
Wall Street price target analysis for RVP.
RVP MoonshotScore
What does this score mean?
The MoonshotScore rates RVP 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Latest Retractable Technologies, Inc. Analysis
Leadership: Thomas J. Shaw
CEO
Thomas J. Shaw serves as the CEO of Retractable Technologies, Inc. His background includes extensive experience in managing and leading companies within the medical device industry. Shaw's expertise encompasses strategic planning, product development, and market expansion. He has a proven track record of driving innovation and improving operational efficiency within healthcare organizations. His leadership is focused on enhancing patient safety and reducing healthcare-associated risks through advanced medical technologies.
Track Record: Under Thomas J. Shaw's leadership, Retractable Technologies has focused on expanding its distribution network and enhancing its product offerings. Key milestones include the introduction of new safety-engineered devices and strategic partnerships aimed at increasing market penetration. Shaw has emphasized the importance of innovation and quality in driving the company's growth. He manages a workforce of 221 employees.
Common Questions About RVP (Healthcare)
What does the AI Score mean for RVP?
RVP holds an AI Score of 37/100 (Grade: D). This is an educational research signal, not a buy or sell recommendation. Retractable Technologies, Inc. specializes in designing, developing, and manufacturing safety syringes and medical products. The company aims to reduce needlestick injuries and enhance patient …
What does Retractable Technologies, Inc. do?
Retractable Technologies, Inc. specializes in the design, development, manufacturing, and marketing of safety syringes and other safety medical products. Its primary focus is on reducing the risk of needlestick injuries and enhancing patient safety within the healthcare industry.
What do analysts say about RVP stock?
Analyst coverage of Retractable Technologies, Inc. (RVP) is limited due to its small market capitalization. Key valuation metrics, such as price-to-earnings ratio, are difficult to assess given the company's current negative profit margin. Growth considerations include the company's ability to increase sales volume, manage costs, and capitalize on regulatory tailwinds favoring safety-engineered medical devices.
What are the main risks for RVP?
Retractable Technologies, Inc. faces several key risks. Competition from larger medical device manufacturers with greater resources and broader product portfolios poses a significant threat. Fluctuations in raw material costs can impact production expenses and profitability. Regulatory changes affecting product approvals and market access could also negatively affect the company.
What are the key factors to evaluate for RVP?
Retractable Technologies, Inc. (RVP) holds an AI score of 37/100 (low). Not financial advice.
How frequently does RVP data refresh on this page?
RVP's price was last updated on Jul 20, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven RVP's recent stock price performance?
Retractable Technologies, Inc. (RVP) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Proprietary VanishPoint technology. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider RVP overvalued or undervalued right now?
Retractable Technologies, Inc. (RVP) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research RVP before investing?
Before investing in Retractable Technologies, Inc. (RVP), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on available data and may be subject to change.
- Financial metrics are based on the most recent filings.
- Analyst opinions may vary.